Bionik Laboratories Debt to Equity Ratio 2014-2023 | BNKL
Current and historical debt to equity ratio values for Bionik Laboratories (BNKL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bionik Laboratories debt/equity for the three months ending March 31, 2023 was 0.00.
| Bionik Laboratories Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-03-31 | $0.01B | $-0.00B | -3.05 |
| 2022-12-31 | $0.00B | $-0.00B | -8.06 |
| 2022-09-30 | $0.00B | $0.00B | 6.32 |
| 2022-06-30 | $0.00B | $0.00B | 1.51 |
| 2022-03-31 | $0.00B | $0.00B | 0.60 |
| 2021-12-31 | $0.01B | $-0.00B | -2.35 |
| 2021-09-30 | $0.01B | $0.00B | 4.33 |
| 2021-06-30 | $0.01B | $0.00B | 1.98 |
| 2021-03-31 | $0.01B | $0.00B | 1.68 |
| 2020-12-31 | $0.01B | $0.00B | 5.19 |
| 2020-09-30 | $0.01B | $0.01B | 0.67 |
| 2020-06-30 | $0.01B | $0.01B | 0.60 |
| 2020-03-31 | $0.01B | $0.01B | 0.39 |
| 2019-12-31 | $0.00B | $0.03B | 0.09 |
| 2019-09-30 | $0.00B | $0.03B | 0.10 |
| 2019-06-30 | $0.01B | $0.03B | 0.18 |
| 2019-03-31 | $0.00B | $0.03B | 0.12 |
| 2018-12-31 | $0.01B | $0.03B | 0.26 |
| 2018-09-30 | $0.00B | $0.03B | 0.07 |
| 2018-06-30 | $0.01B | $0.02B | 0.22 |
| 2018-03-31 | $0.01B | $0.02B | 0.40 |
| 2017-12-31 | $0.01B | $0.02B | 0.55 |
| 2017-09-30 | $0.01B | $0.02B | 0.34 |
| 2017-06-30 | $0.01B | $0.02B | 0.28 |
| 2017-03-31 | $0.01B | $0.02B | 0.20 |
| 2016-12-31 | $0.01B | $0.02B | 0.21 |
| 2016-09-30 | $0.01B | $0.03B | 0.22 |
| 2016-06-30 | $0.01B | $0.02B | 0.31 |
| 2016-03-31 | $0.01B | $0.00B | 22.63 |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.01B | $0.00B | -25.29 |
| 2015-06-30 | $0.01B | $-0.00B | -4.53 |
| 2015-03-31 | $0.01B | $-0.00B | -3.57 |
| 2014-12-31 | $0.00B | $0.00B | -9.21 |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| 2014-06-30 | $0.00B | $0.00B | 0.00 |
| 2014-03-31 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.00B | $0.00B | -1.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.001B | $0.002B |
| Bionik Laboratories Corp. is a medical device and robotics company which focuses in developing transformational technologies and solutions for individuals with neurological disorders. The company offers ARKE, a lower body exoskeleton for wheelchair bound individuals suffering from spinal cord injuries, strokes and other mobility disabilities to restore gait and walk again during the rehabilitation process. It also provides Cronos and the Apollo research programs. Chronos system is a patient queuing system for clinics and hospitals; Apollo is an above-the-knee prosthetic device. Bionik Laboratories Corp. is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.933B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $135.870B | 81.85 |
| DexCom (DXCM) | United States | $51.560B | 78.10 |
| Edwards Lifesciences (EW) | United States | $51.275B | 33.37 |
| IQVIA Holdings (IQV) | United States | $41.367B | 24.00 |
| Alcon (ALC) | Switzerland | $39.650B | 29.24 |
| IDEXX Laboratories (IDXX) | United States | $39.383B | 46.16 |
| STERIS (STE) | Ireland | $20.704B | 24.50 |
| Waters (WAT) | United States | $18.971B | 27.22 |
| Hologic (HOLX) | United States | $17.720B | 19.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.280B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.570B | 15.52 |
| ShockWave Medical (SWAV) | United States | $12.378B | 77.10 |
| Sysmex ADR (SSMXY) | Japan | $11.001B | 34.50 |
| Teleflex (TFX) | United States | $9.466B | 14.73 |
| Penumbra (PEN) | United States | $8.202B | 101.25 |
| Masimo (MASI) | United States | $7.302B | 40.95 |
| Globus Medical (GMED) | United States | $6.805B | 21.58 |
| Glaukos (GKOS) | United States | $5.289B | 0.00 |
| TransMedics (TMDX) | United States | $4.369B | 414.53 |
| Integer Holdings (ITGR) | United States | $3.743B | 22.62 |
| LivaNova (LIVN) | United Kingdom | $3.390B | 20.13 |
| PROCEPT BioRobotics (PRCT) | United States | $3.159B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.810B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.789B | 19.13 |
| Nihon Kohden (NHNKY) | Japan | $2.518B | 21.30 |
| Inari Medical (NARI) | United States | $2.433B | 0.00 |
| RxSight (RXST) | United States | $2.324B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.819B | 7.95 |
| Veracyte (VCYT) | United States | $1.599B | 0.00 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.906B | 17.62 |
| Paragon 28 (FNA) | United States | $0.885B | 0.00 |
| Artivion (AORT) | United States | $0.868B | 84.28 |
| Silk Road Medical (SILK) | United States | $0.824B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.799B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.692B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.624B | 21.20 |
| SiBone (SIBN) | United States | $0.597B | 0.00 |
| IRadimed (IRMD) | United States | $0.552B | 30.92 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.427B | 0.00 |
| Nevro (NVRO) | United States | $0.409B | 0.00 |
| NeuroPace (NPCE) | United States | $0.387B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 11.54 |
| Sight Sciences (SGHT) | United States | $0.288B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| AxoGen (AXGN) | United States | $0.248B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.216B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.195B | 10.48 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Accuray (ARAY) | United States | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.160B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.067B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 125.33 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |